Protein-based therapeutics have transformed treatments for numerous diseases, yet their production remains highly complex and cost-intensive [1][2],[3][4]. Downstream processing (DSP), including ...

Particle size characterization in nanosuspensions often focuses on ‘majority’ features of the size distribution. Yet, for various suspensions in (bio)pharmaceuticals or fine chemicals, small fractions ...

Dynamic Image Analysis directly addresses micro-flow imaging’s inherent scalability and workflow limitations. Both ...

Within several industries, including pharma, cosmetics, inks, coatings, chemicals, food, and more, there are numerous ways to make nanoparticles. A real-time monitoring tool is lacking in commonly ...

Tomographic Particle Image Velocimetry (Tomo-PIV) is a 3D particle image velocimetry technology combined with computed tomography (CT), which can realize full-field quantitative measurement of spatial ...

Recent advancements in particle acceleration technology have led to the discovery of a new method that promises to revolutionize the field. This breakthrough could significantly enhance our ...

In biotherapeutic development, hitting roadblocks due to insufficient developability assessment is a common and costly setback. Traditional particle analysis methods demand more sample volume than is ...

Active principle ingredients (API) and protein aggregation are of the utmost importance when ensuring the usability and stability of injectable biopharmaceutical products. Protein aggregation is a ...